Sapos SRL
Sapos reported total assets of 241,792 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Apr 2026).
The score of Sapos shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +100 % Total assets -36 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sapos's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 18,720 € | ||||
| Equity | 168,041 € | ||||
| Cash | 10,923 € | ||||
| EBITDA | 29,029 € | ||||
| Total assets | 241,792 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 04 Apr 2026
- Year ended 30 Sep 2024filed on 25 Apr 2025
- Year ended 30 Sep 2023filed on 29 Mar 2024
- Year ended 30 Sep 2022filed on 19 Apr 2023
- Year ended 30 Sep 2021filed on 27 Apr 2022
Sapos's financial analysis
- Solvency69.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sapos
Sapos's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0563.373.228
- VAT number
- BE0563373228
- Peppol
- Registered · 0208:0563373228 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2014
- Registered office
- 9300 Aalst
- Latest accounts
- 2025 · filed on 04 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sapos (SRL) has been based in Aalst since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 18,720 € and equity of 168,041 €; its revenue is not published. Its solvency stands at 69.5%, above the median of its sector (44.2%).
Companies similar to Sapos
Companies in the same business, of comparable size and area, outside its group.
- Apotheek VAN Dender Retail sale of pharmaceutical products Ostend · balance sheet 239,581 €
- Pharmacie Lenain Retail sale of pharmaceutical products Châtelet · balance sheet 244,877 €
- Schaffen Pharma Retail sale of pharmaceutical products Diest · balance sheet 246,323 €
- Elapharma Retail sale of pharmaceutical products Brussels · balance sheet 236,353 €
- Apoteek Bellekens Retail sale of pharmaceutical products Antwerp · balance sheet 247,504 €
- Pharma Daive Retail sale of pharmaceutical products Péruwelz · balance sheet 247,671 €
- Lolophar Retail sale of pharmaceutical products Ghent · balance sheet 248,113 €
- DVL Retail sale of pharmaceutical products Dilbeek · balance sheet 235,408 €
Frequently asked questions about Sapos
What is the revenue of Sapos?
Sapos files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sapos?
In Belgium, the VAT number is the company number prefixed with BE: BE0563373228 for Sapos, if the company is VAT-registered. Its company number (CBE) is 0563.373.228.
Where is the registered office of Sapos?
According to the CBE register, the registered office of Sapos is in 9300 Aalst.
What is the equity of Sapos?
At the close of the 2025 financial year, the equity of Sapos amounts to 168,041 €, a solvency of 69.5% of total assets.
Who manages Sapos?
The register lists 2 active mandates at Sapos. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sapos
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →